JZP963-201

JZP963-201

A Phase 2, Prospective, Randomized, Open-Label Study on the Efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the Prevention of Acute Graft-versus-Host-Disease in Adult and Pediatric Patients After Allogeneic Hematopietic Stem Cell Transplant (HSCT)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link